[Idiopathic overactive bladder: What to do in case of anticholinergic failure?].
Service de gynécologie obstétrique et médecine de la reproduction, hôpital Antoine-Béclère, 157, rue de la Porte-de-Trivaux, 92140 Clamart, France.
A-S
AS
Boudy
Service de gynécologie obstétrique et médecine de la reproduction, hôpital Antoine-Béclère, 157, rue de la Porte-de-Trivaux, 92140 Clamart, France. Electronic address: thibault.thubert@abc.aphp.fr.
T
T
Thubert
D000083:Acetanilides / Q000627:therapeutic use*; D065087:Acetylcholine Release Inhibitors / Q000627:therapeutic use; D058667:Adrenergic beta-3 Receptor Agonists / Q000627:therapeutic use*; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000627:therapeutic use*; D006801:Humans; D013844:Thiazoles / Q000627:therapeutic use*; D017211:Treatment Failure; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*
D000083:Acetanilides; D065087:Acetylcholine Release Inhibitors; D058667:Adrenergic beta-3 Receptor Agonists; D018680:Cholinergic Antagonists; D013844:Thiazoles; D019274:Botulinum Toxins, Type A; C520025:mirabegron
Anti-cholinergique; Anticholinergic; Botulinum toxine; Hyperactivité vésicale idiopathique; Idiopathic overactive bladder; Mirabegron; Toxine botulinique